Achieve Life Sciences Inc. Daily Stock Analysis

Daily Stock Analysis, ACHV, Achieve Life Sciences Inc, priceseries

Achieve Life Sciences Inc. Daily Stock Analysis
Stock Information
Open
6.65
Close
6.59
High
7.00
Low
6.52
Previous Close
6.71
Daily Price Gain
-0.12
YTD High
8.61
YTD High Date
Jan 5, 2022
YTD Low
6.33
YTD Low Date
Mar 4, 2022
YTD Price Change
-1.67
YTD Gain
-20.22%
52 Week High
12.95
52 Week High Date
Mar 18, 2021
52 Week Low
6.33
52 Week Low Date
Mar 4, 2022
52 Week Price Change
-5.17
52 Week Gain
-43.96%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 3. 2017
1122.00
Jan 17. 2017
1303.63
9 Trading Days
16.19%
Link
LONG
Aug 29. 2017
738.00
Aug 30. 2017
789.00
1 Trading Days
6.91%
Link
LONG
Oct 26. 2017
436.00
Oct 27. 2017
463.00
1 Trading Days
6.19%
Link
LONG
Dec 7. 2017
292.00
Dec 8. 2017
310.00
1 Trading Days
6.16%
Link
LONG
Dec 22. 2017
254.00
Dec 29. 2017
268.50
4 Trading Days
5.71%
Link
LONG
Jan 29. 2019
28.40
Feb 20. 2019
32.08
15 Trading Days
12.96%
Link
LONG
Feb 21. 2019
35.80
Mar 8. 2019
48.38
11 Trading Days
35.14%
Link
LONG
Mar 14. 2019
49.00
Mar 22. 2019
57.21
6 Trading Days
16.76%
Link
LONG
Apr 22. 2019
77.20
May 9. 2019
81.81
13 Trading Days
5.97%
Link
LONG
Sep 3. 2019
39.80
Sep 12. 2019
42.81
7 Trading Days
7.57%
Link
LONG
Nov 27. 2019
18.43
Nov 29. 2019
19.51
1 Trading Days
5.89%
Link
LONG
Jul 7. 2020
8.46
Jul 8. 2020
8.89
1 Trading Days
5.07%
Link
LONG
Jul 17. 2020
8.56
Jul 23. 2020
9.14
4 Trading Days
6.78%
Link
LONG
Sep 14. 2020
8.96
Sep 21. 2020
9.46
5 Trading Days
5.61%
Link
LONG
Nov 10. 2020
8.62
Nov 17. 2020
9.05
5 Trading Days
5.05%
Link
LONG
Jan 7. 2021
8.61
Feb 18. 2021
13.94
28 Trading Days
61.95%
Link
LONG
Jul 21. 2021
7.93
Jul 22. 2021
8.34
1 Trading Days
5.17%
Link
LONG
Aug 23. 2021
7.24
Sep 7. 2021
8.01
10 Trading Days
10.60%
Link
LONG
Sep 21. 2021
8.11
Sep 29. 2021
8.79
6 Trading Days
8.34%
Link
Company Information
Stock Symbol
ACHV
Exchange
NasdaqCM
Company URL
http://www.oncogenex.com
Company Phone
425-686-1500
CEO
Scott Daniel Cormack
Headquarters
Washington
Business Address
19820 NORTH CREEK PARKWAY, SUITE 201, BOTHELL, WA 98011
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000949858
About

OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA.

Description

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading